Edition:
United States

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

1.79USD
14 Nov 2018
Change (% chg)

$-0.07 (-3.76%)
Prev Close
$1.86
Open
$1.92
Day's High
$1.92
Day's Low
$1.79
Volume
158,875
Avg. Vol
146,426
52-wk High
$108.00
52-wk Low
$1.79

Latest Key Developments (Source: Significant Developments)

Neovasc Inc - QTRLY Loss Per Share $0.70
Wednesday, 14 Nov 2018 04:00pm EST 

Neovasc Inc ::NEOVASC ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.NEOVASC INC - QTRLY LOSS PER SHARE $0.70.  Full Article

Neovasc Provides Initial Comments On Lawsuit
Tuesday, 11 Sep 2018 07:20am EDT 

Sept 11 (Reuters) - Neovasc Inc ::NEOVASC PROVIDES INITIAL COMMENTS ON LAWSUIT.NEOVASC INC - COMPLAINT HAS NOT YET BEEN SERVED ON COMPANY.NEOVASC INC - MADE AWARE OF A LAWSUIT FILED BY ENDOVALVE INC. AND MICRO INTERVENTIONAL DEVICES, INC.NEOVASC INC - IF PLAINTIFFS DO SERVE COMPLAINT, CO INTENDS TO DEFEND THE LAWSUIT.NEOVASC - FILED LAWSUIT FOR SOME ALLEGATIONS RELATING TO NEOVASC'S TRANSCATHETER MITRAL VALVE TECHNOLOGY, INCLUDING TIARA DEVICE.  Full Article

Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc
Monday, 11 Dec 2017 11:38am EST 

Dec 11 (Reuters) - Neovasc Inc ::CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING.  Full Article

Neovasc announces 65 million dollars offering of common shares and warrants
Friday, 10 Nov 2017 01:15am EST 

Nov 10 (Reuters) - NEOVASC INC ::NEOVASC ANNOUNCES US$65 MILLION UNDERWRITTEN OFFERING OF UNITS CONSISTING OF COMMON SHARES AND WARRANTS TO PURCHASE COMMON SHARES AND CONCURRENT PRIVATE PLACEMENT OF NOTES AND WARRANTS.‍PRICE OF US$1.46 PER UNIT FOR GROSS PROCEEDS OF APPROXIMATELY US$37.487 MILLION​.WILL ALSO COMPLETE BROKERED PRIVATE PLACEMENT FOR SALE OF US$32,750,000 AGGREGATE PRINCIPAL AMOUNT OF SENIOR SECURED CONVERTIBLE NOTES FOR GROSS PROCEEDS OF US$27,837,500​.‍ CANACCORD GENUITY INC. IS ACTING AS SOLE BOOK-RUNNING MANAGER FOR OFFERING​.‍CANACCORD GENUITY INC ACTS ALSO AS SOLE PLACEMENT AGENT FOR CONCURRENT PRIVATE PLACEMENT​.  Full Article

Neovasc receives FDA approval to initiate pivotal reducer trial
Monday, 6 Nov 2017 07:00am EST 

Nov 6 (Reuters) - Neovasc Inc :Neovasc receives FDA approval to initiate pivotal reducer trial.Neovasc Inc - ‍Co is currently evaluating start up timelines and funding options for Cosira-II trial​.  Full Article

Neovasc provides litigation update
Friday, 3 Nov 2017 02:45pm EDT 

Nov 3 (Reuters) - Neovasc Inc :Neovasc provides litigation update.Says Court Of Appeals affirmed judgment of U.S. District Court for District of Massachusetts in case of Cardiaq Valve Tech versus co.Says ‍full judgment of about US$112 million will now become due on November 13, 2017​.  Full Article

Neovasc says appeals court upholds lower court decisions but denies injunction in Cardiaq case
Friday, 1 Sep 2017 12:26pm EDT 

Sept 1 (Reuters) - Neovasc Inc ::Decision from appeals court upholds lower court decisions but denies injunction.Panel of U.S. court of appeals affirmed judgment of U.S. court in case of cardiaq valve tech versus neovasc ​.‍If judgement is not altered through additional appellate proceedings, Neovasc must pay full judgement of approximately US$112 million​.‍Panel also affirmed district court's decision not to enjoin Neovasc's Tiara program​.‍Presently considering whether to pursue further appellate review of panel's decisions on other issues presented by judgment​.‍There are no other monetary damages arising from judgement, Neovasc remains joint inventor of '964 patent​.  Full Article

Neovasc reports Q2 loss per share $0.07
Thursday, 10 Aug 2017 04:00pm EDT 

Aug 10 (Reuters) - Neovasc Inc -:Neovasc announces results for the second quarter of 2017.Q2 revenue fell 24 percent to $1.305 million.Qtrly loss per share $0.07.  Full Article

Neovasc says German Court partially found in favor of Edwards Lifesciences in its case against co
Friday, 16 Jun 2017 10:44am EDT 

June 16 (Reuters) - Neovasc Inc ::Neovasc announces German Court ruling.District court in Munich has partially found in favour of Edwards Lifesciences Corporation in its case against Neovasc.German Court found CardiAQ had contributed in part to invention of Tiara, awarded to CardiAQ co-entitlement rights to disputed Tiara European patent application.Neovasc intends to appeal Court's decision.There are no monetary awards associated with the Court ruling.Currently appealing 2016 decision from U.S Court which granted co-inventorship rights to Edwards on one of co's granted U.S. patent applications.Expects oral argument on appeal regarding the 2016 decision by U.S. Court in August 2017 and ruling is expected to follow, prior to end of 2017.  Full Article

Neovasc qtrly loss per share $0.10
Wednesday, 10 May 2017 04:00pm EDT 

May 10 (Reuters) - Neovasc Inc ::Neovasc announces results for the first quarter of 2017.Q1 revenue fell 26 percent to $1.481 million.Neovasc Inc qtrly loss per share $0.10.  Full Article

BRIEF-Neovasc's Management And Board Of Directors Urge Shareholders To Vote In Favor Of The Proposed Reverse Stock Split

* NEOVASC'S MANAGEMENT AND BOARD OF DIRECTORS URGE SHAREHOLDERS TO VOTE IN FAVOR OF THE PROPOSED REVERSE STOCK SPLIT AT THE UPCOMING ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS